People channel feed

In wake of do­mes­tic vi­o­lence al­le­ga­tion, long­time Seagen CEO Clay Sie­gall goes on leave

4 years ago
R&D

Ava­lo Ther­a­peu­tics to lay off 33% of staff amidst mar­ket strug­gles and pen­ny stock sta­tus

4 years ago
Pharma

Days af­ter flag­ging its $773M takeover bid, Zymeworks mi­nor­i­ty share­hold­er adds As­traZeneca on­col­o­gy vet to the crew

4 years ago

Bio­gen CEO Vounatsos, board and top ex­ecs for­mal­ly agreed to keep the breakup civ­il

4 years ago

Fol­low­ing stu­dent and fac­ul­ty protests, David Saba­ti­ni with­draws from NYU job con­sid­er­a­tion

4 years ago

Frank Zhang is in the clear af­ter Chi­nese au­thor­i­ties con­clude in­ves­ti­ga­tion with­out charges, com­pa­ny says

4 years ago
China
Law

Two strug­gling biotechs fall un­der bear mar­ket in­flu­ence, as Spero sharply re­duces staff and Sesen seeks sale

4 years ago
R&D

Michel Vounatsos is on his way out as Bio­gen shut­ters Aduhelm ef­fort and launch­es pipeline re­org

4 years ago
R&D

Fifth in­di­vid­ual charged in con­spir­a­cy to steal Glax­o­SmithK­line trade se­crets, faces up to 10-year sen­tence

4 years ago
Pharma

Fac­ing back­lash for po­ten­tial Saba­ti­ni ap­point­ment, NYU ad­min­is­tra­tors de­fend hir­ing process — re­port

4 years ago

Klick Health hires big-name cre­ative tal­ent, adds new style ti­tle and work­ing group

4 years ago
Pharma
Marketing

Af­ter culling work­force, mi­graine biotech Zosano drops lead — and sole — pro­gram

4 years ago
R&D

A for­mer Gary Glick biotech, now a pen­ny stock, will lay off staff and close of­fices af­ter PhII fail

4 years ago

Just weeks af­ter he stepped down as chair­man, Emer­gen­t's for­mer CEO dies at age 64

4 years ago
Pharma
Manufacturing

James Boy­lan snags $300M to hunt for biotech deals af­ter leav­ing SVB

4 years ago
Financing
Startups

Af­ter spear­head­ing his­toric Covid ef­fort, Pfiz­er vac­cine R&D chief Kathrin Jansen to re­tire

4 years ago

Aduhelm strug­gles bare­ly af­fect­ed CEO Michel Vounatsos' $17.7M pay

4 years ago

Five years in­to neoanti­gen work, cash-strapped Geno­cea lays off staff as it looks for 's­trate­gic al­ter­na­tives'

4 years ago

Y-mAb­s' long­time CEO steps down abrupt­ly as FDA re­views sec­ond pe­di­atric can­cer drug

4 years ago

Scoop: Af­ter fail­ing to se­cure more funds, a pri­vate gene ther­a­py de­vel­op­er lays off staff

4 years ago
Pharma
Cell/Gene Tx

Ax­o­vant-turned-Sio ditch­es two re­main­ing pro­grams, lays off most em­ploy­ees and will seek a buy­er

4 years ago
Cell/Gene Tx

Hun­dreds at NYU walk out in protest of re­ports that David Saba­ti­ni may join fac­ul­ty

4 years ago
Pharma

Mod­er­na CEO Stéphane Ban­cel plucks new com­mer­cial chief from Mer­ck­'s top ex­ec­u­tive team

4 years ago
Pharma

Lay­offs hit an­oth­er biotech as Duchenne play­er Sol­id Bio cuts staff by 35%

4 years ago
R&D
First page Previous page 44454647484950 Next page Last page
A service from the Financial Times